MedTrace Logo

Evaluating Mutations in MET and TP53 Among Patients Diagnosed With Squamous Cell Carcinoma

NCT03938012 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2019-05-06

No results posted yet for this study

Summary

This study focuses on advanced lung and head and neck SCC tumours, with adjacent normal lung tissues. Biopsies will be performed in National University Health System, Singapore (NUHS) as part of participants' standard care. Patient blood was also required for extraction of cell free DNA (cfDNA) and genomic DNA (gDNA). Patients' medical records will also be reviewed for the purpose of this study.

Conditions

  • Squamous Cell Carcinoma of the Lung
  • Squamous Cell Carcinoma of the Head and Neck

Sponsors & Collaborators

  • National University Hospital, Singapore

    lead OTHER

Principal Investigators

  • Boon Cher Goh · Study Principal Investigator

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-03
Primary Completion
2021-10-31
Completion
2022-10-31

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03938012 on ClinicalTrials.gov